GlobeNewswire Inc.··Coloplast A/SColoplast Faces Headwinds as Medicare Pressures Kerecis, Impairs DKK 3B Goodwill
Coloplast posts 6% organic revenue growth in H1 2025/26 but takes DKK 3B Kerecis impairment due to Medicare reimbursement challenges, revising full-year guidance.
CLPBYorganic growthMedicare reimbursement